|
N4BP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.022180E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.326000E-01 |
| Normal-vs-Stage2 |
1.417980E-01 |
| Normal-vs-Stage3 |
9.979700E-04 |
| Normal-vs-Stage4 |
1.884160E-03 |
| Stage1-vs-Stage2 |
6.425500E-02 |
| Stage1-vs-Stage3 |
1.88878999999309E-05 |
| Stage1-vs-Stage4 |
1.207580E-04 |
| Stage2-vs-Stage3 |
4.723600E-01 |
| Stage2-vs-Stage4 |
3.751200E-01 |
| Stage3-vs-Stage4 |
7.329200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.259810E-01 |
| Normal-vs-AfricanAmerican |
9.461800E-02 |
| Normal-vs-Asian |
5.822200E-01 |
| Caucasian-vs-AfricanAmerican |
4.489800E-01 |
| Caucasian-vs-Asian |
9.919600E-01 |
| AfricanAmerican-vs-Asian |
7.840000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.017210E-01 |
| Normal-vs-Female |
2.101200E-01 |
| Male-vs-Female |
7.465200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.778440E-01 |
| Normal-vs-Age(41-60Yrs) |
9.032000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.164500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.974110E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.616000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.523000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.668400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.724500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.479700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.219400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.540300E-03 |
| Normal-vs-Grade 2 |
8.875800E-01 |
| Normal-vs-Grade 3 |
2.209800E-02 |
| Normal-vs-Grade 4 |
5.437700E-04 |
| Grade 1-vs-Grade 2 |
1.909830E-02 |
| Grade 1-vs-Grade 3 |
3.364600E-04 |
| Grade 1-vs-Grade 4 |
3.71920000000747E-05 |
| Grade 2-vs-Grade 3 |
4.704500E-03 |
| Grade 2-vs-Grade 4 |
2.791400E-04 |
| Grade 3-vs-Grade 4 |
7.796100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.706600E-01 |
| Normal-vs-ccB subtype |
5.345900E-02 |
| ccA subtype-vs-ccB subtype |
4.818400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.821620E-01 |
| Normal-vs-N1 |
2.348800E-01 |
| N0-vs-N1 |
6.521600E-01 |
|
|
